These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15120893)

  • 1. Studies on controlled release effervescent osmotic pump tablets from Traditional Chinese Medicine Compound Recipe.
    Li XD; Pan WS; Nie SF; Wu LJ
    J Control Release; 2004 May; 96(3):359-67. PubMed ID: 15120893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on preparation and release mechanism of effervescent osmotic pump tablet of compound Danshen].
    Xue L; Li Y; Guo D; Yin J; Liu Y; Hou S
    Zhongguo Zhong Yao Za Zhi; 2009 Apr; 34(7):848-51. PubMed ID: 19623978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applicability of (SBE)7m-beta-CD in controlled-porosity osmotic pump tablets (OPTs).
    Okimoto K; Tokunaga Y; Ibuki R; Irie T; Uekama K; Rajewski RA; Stella VJ
    Int J Pharm; 2004 Nov; 286(1-2):81-8. PubMed ID: 15501004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel controlled porosity osmotic pump system for sodium ferulate.
    He L; Gong T; Zhao D; Zhang ZR; Li L
    Pharmazie; 2006 Dec; 61(12):1022-7. PubMed ID: 17283661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel two-step release system for the traditional Chinese medicine compound Danshen.
    Li Y; Hou S; Bi Y; Zheng Y; Cai Z; Cheng Q; Song X
    Yakugaku Zasshi; 2007 Sep; 127(9):1473-84. PubMed ID: 17827927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Swellable elementary osmotic pump (SEOP): an effective device for delivery of poorly water-soluble drugs.
    Shokri J; Ahmadi P; Rashidi P; Shahsavari M; Rajabi-Siahboomi A; Nokhodchi A
    Eur J Pharm Biopharm; 2008 Feb; 68(2):289-97. PubMed ID: 17616378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of a 24-hour controlled porosity osmotic pump system containing PVP: formulation variables.
    Yakubu R; Peh KK; Tan YT
    Drug Dev Ind Pharm; 2009 Dec; 35(12):1430-8. PubMed ID: 19929202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel time-controlled release system based on drug-resin complexes and elementary osmotic pump.
    Wang C; Chen F; Heng PW; Li JZ; Li X; Ye GH; Nie SF; Pan WS
    Chem Pharm Bull (Tokyo); 2008 Apr; 56(4):457-63. PubMed ID: 18379090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sandwiched osmotic tablet core for nifedipine controlled delivery.
    Liu L; Khang G; Rhee JM; Lee HB
    Biomed Mater Eng; 1999; 9(5-6):297-310. PubMed ID: 10822485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and evaluation of compound metformin/glipizide elementary osmotic pump tablets.
    Ouyang D; Nie S; Li W; Guo H; Liu H; Pan W
    J Pharm Pharmacol; 2005 Jul; 57(7):817-20. PubMed ID: 15969939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigations of a novel self-emulsifying osmotic pump tablet containing carvedilol.
    Wei L; Li J; Guo L; Nie S; Pan W; Sun P; Liu H
    Drug Dev Ind Pharm; 2007 Sep; 33(9):990-8. PubMed ID: 17891586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and evaluation of jingzhiguanxin monolithic osmotic pump tablet.
    Yang XG; Zhang GH; Li W; Peng B; Liu ZD; Pan WS
    Chem Pharm Bull (Tokyo); 2006 Apr; 54(4):465-9. PubMed ID: 16595946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Formulation optimization of controlled porosity osmotic-pump tablets of total paeony glycosides].
    Zhang H; Wang WP
    Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(19):2185-7. PubMed ID: 19166002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inlay osmotic pump tablets containing metformin and glipizide.
    Patel RB; Patel GN; Patel HR; Patel MM
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1244-52. PubMed ID: 21466414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymmetric membrane capsules for delivery of poorly water-soluble drugs by osmotic effects.
    Wang CY; Ho HO; Lin LH; Lin YK; Sheu MT
    Int J Pharm; 2005 Jun; 297(1-2):89-97. PubMed ID: 15885936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immediate release of poorly soluble drugs from starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; Remon JP; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2007 Nov; 67(3):715-24. PubMed ID: 17537625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of monolithic osmotic pump system by coating the indented core tablet.
    Liu L; Che B
    Eur J Pharm Biopharm; 2006 Oct; 64(2):180-4. PubMed ID: 16797951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and evaluation of osmotic pump tablets of naproxen sodium.
    Ramakrishna N; Mishra B
    Pharmazie; 2001 Dec; 56(12):958-62. PubMed ID: 11802660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solubility-modulated monolithic osmotic pump tablet for atenolol delivery.
    Liu L; Wang X
    Eur J Pharm Biopharm; 2008 Feb; 68(2):298-302. PubMed ID: 17560099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.